A new surgical strategy for medically uncontrolled protein-losing enteropathy after Fontan surgery

Seul Gi Cha1, Gi Beom Kim1, Chung Il Noh1

  • 1Department of Pediatrics, Seoul National University Children's Hospital, Seoul, South Korea.

Insights

Managing protein-losing enteropathy after Fontan surgery is difficult. Surgical intervention involving Fontan takedown and pulsatile bidirectional cavopulmonary shunting successfully treated a pediatric patient unresponsive to medical management.

Area of Science:

  • Cardiology
  • Pediatric Gastroenterology
  • Surgical Innovation

Background:

  • Protein-losing enteropathy (PLE) is a challenging complication following Fontan surgery.
  • Managing PLE in patients with Fontan circulation requires innovative therapeutic strategies.

Observation:

  • A 14-year-old boy with Fontan circulation developed protein-losing enteropathy.
  • The patient underwent two years of medical treatment without significant clinical improvement.

Findings:

  • Surgical intervention, including Fontan takedown and conversion to pulsatile bidirectional cavopulmonary shunting, resolved the protein-losing enteropathy.
  • This case highlights the potential efficacy of surgical revision in refractory PLE post-Fontan.

Implications:

  • Fontan takedown and conversion to pulsatile flow may be a viable treatment option for intractable protein-losing enteropathy.
  • This approach could improve outcomes for Fontan patients experiencing severe gastrointestinal complications.

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
829
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.7K
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
266
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
221
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
370
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
360